Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children

BACKGROUND: As SARS-CoV-2 will likely continue to circulate, low-impact methods become more relevant to monitor antibody-mediated immunity. Saliva sampling could provide a non-invasive method with reduced impact on children. Studies reporting on the differences between systemic and mucosal humoral i...

Descripción completa

Detalles Bibliográficos
Autores principales: Keuning, Maya W., Grobben, Marloes, Bijlsma, Merijn W., Anker, Beau, Berman-de Jong, Eveline P., Cohen, Sophie, Felderhof, Mariet, de Groen, Anne-Elise, de Groof, Femke, Rijpert, Maarten, van Eijk, Hetty W. M., Tejjani, Khadija, van Rijswijk, Jacqueline, Steenhuis, Maurice, Rispens, Theo, Plötz, Frans B., van Gils, Marit J., Pajkrt, Dasja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500453/
https://www.ncbi.nlm.nih.gov/pubmed/36159841
http://dx.doi.org/10.3389/fimmu.2022.976382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500453/
https://www.ncbi.nlm.nih.gov/pubmed/36159841
http://dx.doi.org/10.3389/fimmu.2022.976382

Ejemplares similares